Diederik S.
- Country
- The Netherlands
- Department
- Urologie
Research Overview
- Phase III Comparative Study of Docetaxel Versus Docetaxel Plus Radium-223 Dichloride in Metastatic Castration-Resistant Prostate Cancer
- Evaluation of [18F]PSMA-1007 PET/CT Imaging for Detecting Pelvic Nodal Metastases in High-Risk Prostate Cancer Patients
- Evaluation of Shortened 12-Month Androgen Receptor Signaling Inhibitor Therapy with Androgen Deprivation in Low-Volume Metastatic Castration-Sensitive Prostate Cancer
Data & Insights
Has run more than one trial at 159 of 333 partner sites.
Specializations
Urologic Oncology
This investigator specializes in the treatment and research of urological cancers, with particular expertise in bladder cancer and prostate cancer management.
- Non-muscle invasive bladder cancer treatments
- Advanced therapeutic approaches for high-risk bladder conditions
- Prostate cancer diagnostics and staging
Their work encompasses innovative therapeutic strategies for patients who have not responded to conventional treatments.
Diagnostic Imaging
The investigator focuses on advanced diagnostic imaging techniques, particularly in the field of molecular imaging for urologic cancers.
- PET-CT imaging applications
- PSMA-based diagnostic protocols
- Nodal staging methodologies
Their research integrates cutting-edge imaging technologies for precise cancer detection and staging.
Treatment Innovation
The investigator explores novel therapeutic combinations and targeted treatment approaches for urological malignancies.
- Immunotherapy applications
- Combination therapy strategies
- Alternative treatment options for surgery-ineligible patients
Their research includes evaluation of response rates and disease-free survival in various treatment modalities.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.